Evidence map›Paper›PMID 19139066›Full record

ArticleNucleic acids research2009

How binding of small molecule and peptide ligands to HIV-1 TAR alters the RNA motional landscape.

Michael F Bardaro, Zahra Shajani, Krystyna Patora-Komisarska, John A Robinson, Gabriele Varani

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 64 citations in OpenAlex.

  1. Journal of molecular biology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Structure of a low-population binding intermediate in protein-RNA recognition.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Michael F BardaroDepartment of Chemistry, University of Washington, Seattle, WA 98195-1700, USA.
Zahra Shajani
Krystyna Patora-Komisarska
John A Robinson
Gabriele Varani
University of Washington · USUniversity of Zurich · CH

Funding

New Inhibitors of HIV ReplicationR01AI070090 · NIAID · UNIVERSITY OF WASHINGTON · PI VARANI, GABRIELE · 2007 to 2011
$2.1M
New Inhibitors of HIV replicationR01GM110569 · NIGMS · UNIVERSITY OF WASHINGTON · PI KARN, JONATHAN, VARANI, GABRIELE · 2013 to 2016
$1.7M
NIAID NIH HHS AI070090NIAID NIH HHS R01 AI070090
6 · The paper itself

Abstract

The HIV-1 TAR RNA represents a well-known paradigm to study the role of dynamics and conformational change in RNA function. This regulatory RNA changes conformation in response to binding of Tat protein and of a variety of peptidic and small molecule ligands, indicating that its conformational flexibility and intrinsic dynamics play important roles in molecular recognition. We have used (13)C NMR relaxation experiments to examine changes in the motional landscape of HIV-1 TAR in the presence of three ligands of different affinity and specificity. The ligands are argininamide, a linear peptide mimic of the Tat basic domain and a cyclic peptide that potently inhibits Tat-dependent activation of transcription. All three molecules induce the same motional characteristics within the three nucleotides bulge that represents the Tat-binding site. However, the cyclic peptide has a unique motional signature in the apical loop, which represents a binding site for the essential host co-factor cyclin T1. These results suggest that all peptidic mimics of Tat induce the same dynamics in TAR within this protein binding site. However, the new cyclic peptide mimic of Tat represents a new class of ligands with a unique effect on the dynamics and the structure of the apical loop.

Indexed as

HIV Long Terminal RepeatArginineHIV-1LigandsModels, MolecularMotionNuclear Magnetic Resonance, BiomolecularNucleic Acid ConformationPeptides, CyclicRNA, Viraltat Gene Products, Human Immunodeficiency VirusargininamideArginineLigandsPeptides, CyclicRNA, Viraltat Gene Products, Human Immunodeficiency Virus

Identifiers

PMID19139066
PMCPMC2655691
OpenAlexW2155603742

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.